Manesh Raman Patel, MD

Professor of Medicine
Chief, Division of Cardiology
Chief, Division of Clinical Pharmacology
Member in the Duke Clinical Research Institute
Campus mail 2301 Erwin Road, Hafs Building, Room 8695, Durham, NC 27710
Phone (919) 681-4441
Email address manesh.patel@duke.edu

Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology.  His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention.  His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging.  He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee.

Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research.  His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award.   In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology.  In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award.

Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.

In Their Words

Education and Training

  • Fellow In Cardiology, Medicine, Duke University, 2002 - 2006
  • Fellow In Cardiology, Medicine, Duke University, 2000 - 2001
  • Medical Resident, Medicine, Duke University, 1997 - 2000
  • M.D., Emory University, 1997

Publications

Selker, HP, Udelson, JE, Ruthazer, R, D'Agostino, RB, Nichols, M, Ben-Yehuda, O, Eitel, I, Granger, CB, Jenkins, P, Maehara, A, Patel, MR, Ohman, EM, Thiele, H, and Stone, GW. "Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials." American heart journal 188 (June 2017): 18-25. (Review)

PMID
28577674
Full Text

Hoffmann, U, Ferencik, M, Udelson, JE, Picard, MH, Truong, QA, Patel, MR, Huang, M, Pencina, M, Mark, DB, Heitner, JF, Fordyce, CB, Pellikka, PA, Tardif, J-C, Budoff, M, Nahhas, G, Chow, B, Kosinski, AS, Lee, KL, Douglas, PS, and PROMISE Investigators, . "Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)." Circulation 135, no. 24 (June 2017): 2320-2332.

PMID
28389572
Full Text

Kosmidou, I, Redfors, B, Selker, HP, Thiele, H, Patel, MR, Udelson, JE, Magnus Ohman, E, Eitel, I, Granger, CB, Maehara, A, Kirtane, A, Généreux, P, Jenkins, PL, Ben-Yehuda, O, Mintz, GS, and Stone, GW. "Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials." European heart journal 38, no. 21 (June 2017): 1656-1663.

PMID
28407050
Full Text

Balla, SR, Cyr, DD, Lokhnygina, Y, Becker, RC, Berkowitz, SD, Breithardt, G, Fox, KAA, Hacke, W, Halperin, JL, Hankey, GJ, Mahaffey, KW, Nessel, CC, Piccini, JP, Singer, DE, and Patel, MR. "Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)." The American journal of cardiology 119, no. 12 (June 2017): 1989-1996.

PMID
28477860
Full Text

Turley, RS, Mi, X, Qualls, LG, Vemulapalli, S, Peterson, ED, Patel, MR, Curtis, LH, and Jones, WS. "The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries." JACC. Cardiovascular interventions 10, no. 11 (June 2017): 1161-1171.

PMID
28595885
Full Text

Jones, WS, Hiatt, WR, and Patel, MR. "Response by Jones et al to Letter Regarding Article, "Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease"." Circulation 135, no. 23 (June 2017): e1109-e1110. (Letter)

PMID
28584036
Full Text

Patel, MR, Calhoon, JH, Dehmer, GJ, Grantham, JA, Maddox, TM, Maron, DJ, and Smith, PK. "ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons." Journal of the American College of Cardiology 69, no. 17 (May 2017): 2212-2241.

PMID
28291663
Full Text

Davies, JE, Sen, S, Dehbi, H-M, Al-Lamee, R, Petraco, R, Nijjer, SS, Bhindi, R, Lehman, SJ, Walters, D, Sapontis, J, Janssens, L, Vrints, CJ, Khashaba, A, Laine, M, Van Belle, E, Krackhardt, F, Bojara, W, Going, O, Härle, T, Indolfi, C, Niccoli, G, Ribichini, F, Tanaka, N, Yokoi, H, Takashima, H, Kikuta, Y, Erglis, A, Vinhas, H, Canas Silva, P, Baptista, SB, Alghamdi, A, Hellig, F, Koo, B-K, Nam, C-W, Shin, E-S, Doh, J-H, Brugaletta, S, Alegria-Barrero, E, Meuwissen, M, Piek, JJ, and van Royen, N et al. "Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI." The New England journal of medicine 376, no. 19 (May 2017): 1824-1834.

PMID
28317458
Full Text

Orgel, R, Wojdyla, D, Huberman, D, Halperin, JL, Breithardt, G, Singer, DE, Fox, KAA, Hankey, GJ, Mahaffey, KW, Jones, WS, and Patel, MR. "Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)." Circulation. Cardiovascular quality and outcomes 10, no. 5 (May 2017).

PMID
28495674
Full Text

Peacock, WF, Tamayo, S, Patel, M, Sicignano, N, Hopf, KP, and Yuan, Z. "CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban." Annals of emergency medicine 69, no. 5 (May 2017): 541-550.e1.

PMID
27913059
Full Text

Pages